Saturday 30 May 2020
Home      All news      Contact us      India
oneindia.com - 7 days ago

Lancet study finds no benefit for hydroxychloroquine in COVID-19 patients

Boston, May 22: Treatment for COVID-19 with the antimalarial drug hydroxychloroquine, either with or without the antibiotic azithromycin, offers no benefit for COVID-19 patients, according to a large observational study. The research, published in the journal The Lancet,


Latest News
Hashtags:   

Lancet

 | 

study

 | 

finds

 | 

benefit

 | 

hydroxychloroquine

 | 

COVID

 | 

patients

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources